Author:
Iqbal Muzaffar,Ezzeldin Essam,Al-Rashood Khalid A.,Asiri Yousif A.,Rezk Naser L.
Funder
Deanship of Scientific Research and Research Center, College of Pharmacy, King Saud University
Reference19 articles.
1. SGLT2-INHIBITORS: A NOVEL CLASS FOR THE TREATMENT OF TYPE 2 DIABETES INTRODUCTION OF SGLT2-INHIBITORS IN CLINICAL PRACTICE
2. Canagliflozin: First Global Approval
3. U.S. FDA Approves Canagliflozin (TA-7284) for the Treatment of Adult Patients with Type 2 Diabetes, 2013, Janssen Pharmaceuticals, Inc.: USA.
4. INVOKANA™ (Canagliflozin) Approved In The European Union For Treatment Of Adults With Type 2 Diabetes, 2013, Janssen-Cilag International NV: Belgium.
5. Renal glucose reabsorption inhibitors to treat diabetes
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献